As an attractant, IL-33 can promote the recruitment of Th2-associated cytokines, which act as key mediators for the recruitment of neutrophils, monocytes, NK cells, dendritic cells or T lymphocytes in inflammatory conditions at the site of tumor (Brabcova et al., 2014). Here, IL33 is linked to neoplasm.